Sales revenue of Yitai Coal fell 14.9% to 8.075 billion yuan
Yitai Coal recently announced that in the fourth quarter of 2019, the coal output was 16.0522 million tons, an increase of 17.45% on a year-on-year basis; the sales of coal was 22.2796 million tons, a decrease of 7.21% on a year-on-year basis. In the fourth quarter, sales revenue was 8.075 billion yuan, a year-on-year decrease of 14.90%; sales cost was 5.344 billion yuan, a year-on-year decrease of 25.15%; gross sales profit was 2.731 billion yuan, a year-on-year increase of 16.25%. According to the announcement, the above production and operation data are derived from the company's internal statistics and are used by investors to timely understand the company's production and operation profile, which may be different from the data disclosed in the company's regular report. Investors should be aware that improper trust or use of the above information may cause investment risks.
2026-10-18
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
Coal Price Surge Coupled with El Niño Drives Urea Up by RMB 100/Ton in a Single Day
-
Coal prices soared, South Africa's Thungela company doubled its annual profit
-
Chemical Enterprises Collectively Stop Production! Supply 'Urgent'
-
Power coal price in Zhejiang Province decreased by 4.0% YoY
-
Oil And Coal Fell, With Collapse And Plasticization Market! PE, PP Fell Over 300
-
The Output Of Major Energy Products Increased Year-on-year in November
-
Mitsubishi Chemical Announces: Withdrawal from Petrochemical And Coal Chemical Business
-
Pure benzene price rebound
-
[ethylene glycol] : Coal fell rapidly, ethylene glycol followed
-
The National Bureau of Statistics release China's energy production in July
Recommend Reading
-
Wegovy Slips on Price While Mounjaro Defends Its Weight-Loss Crown
-
A New Obesity Pill Enters the Arena With Double-Digit Weight Loss
-
Lilly’s Mounjaro Enters China’s State Insurance System
-
Vertex Pushes Gene Therapy Into Younger Children With Blood Disorders
-
Smog Becomes a Sales Catalyst as Respiratory Drugs Surge in November
-
Cost Floor, Supply-Demand Shift—Butadiene Rises First, Then Falls
-
Premium Global Chemical Sourcing Requests (12-14Oct.,2026)
-
Business Society’s Acetone Trend Analysis for September 15, 2026: Operating at High Levels
-
Business Society’s Acrylic Acid Trend Analysis for September 16, 2026: Strong Consolidation
-
Business Society, October 15, 2026: Fuel Oil 180CST Trend Analysis – Volatility